These facts indicate that Hsp47 could be an interesting therapeutic target in collagen-related skin disorders, as alternative to non-specific collagen inducers such as TGF β [68], VEGF [69] or ascorbic acid [17, 18]. Here, SERPINH1 is linked to skin disorder.